(Q46007453)

18 December 2017

title

Human genetics as a foundation for innovative drug development. (English)

1 reference

18 December 2017

1 reference

Alexander Kamb

1

1 reference

18 December 2017

Sean Harper

series ordinal

2

1 reference

18 December 2017

Kari Stefansson

series ordinal

3

1 reference

18 December 2017

publication date

1 November 2013

1 reference

18 December 2017

published in

Nature Biotechnology

1 reference

18 December 2017

volume

31

1 reference

18 December 2017

issue

11

1 reference

18 December 2017

page(s)

975-978

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1038/nbt.2732

exact match

0 references

cites work

A gene complex controlling segmentation in Drosophila

1 reference

Role of epidermal growth factor receptor inhibitors in epidermal growth factor receptor wild-type non-small-cell lung cancer

21 January 2018

1 reference

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

Genetic correction of PSA values using sequence variants associated with PSA levels

21 January 2018

1 reference

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

Effects of dalcetrapib in patients with a recent acute coronary syndrome

21 January 2018

1 reference

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

21 January 2018

1 reference

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

21 January 2018

1 reference

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

21 January 2018

1 reference

The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population

21 January 2018

1 reference

21 January 2018

1 reference

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

21 January 2018

1 reference

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses

21 January 2018

1 reference

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

21 January 2018

1 reference

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

21 January 2018

1 reference

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

21 January 2018

1 reference

The value of lowering cholesterol after myocardial infarction

21 January 2018

1 reference

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

Lifetime risk of developing coronary heart disease

21 January 2018

1 reference

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

Pathologic assessment of the vulnerable human coronary plaque

21 January 2018

1 reference

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

21 January 2018

1 reference

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis

21 January 2018

1 reference

21 January 2018

1 reference

PCSK9: a convertase that coordinates LDL catabolism

21 January 2018

1 reference

Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels

21 January 2018

1 reference

A rare variant in MYH6 is associated with high risk of sick sinus syndrome

21 January 2018

1 reference

A new grammar for drug discovery

21 January 2018

1 reference

The Framingham study of coronary disease in women.

21 January 2018

1 reference

12 December 2020

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

How to improve R&D productivity: the pharmaceutical industry's grand challenge

1 reference

12 December 2020

Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred

1 reference

12 December 2020

Identifiers

DOI

10.1038/NBT.2732

1 reference

18 December 2017

Dimensions Publication ID

1039972293

0 references

1 reference

18 December 2017